Hepatitis E Virus

Hepatitis E virus (HEV) is a nonenveloped ribonucleic acid (RNA) virus that is responsible for large epidemics and sporadic cases of self-limiting, enterically transmitted, acute viral hepatitis in developing countries.

Keywords: viral hepatitis; Hepevirus; enterically transmitted disease; epidemics; sporadic

Figure 1. Geographical distribution of hepatitis E virus (HEV) endemicity. The blue-shaded areas represent disease-endemic regions.
Figure 2. HEV-like particles. An immunoelectron micrograph of HEV from the stool of a patient acutely infected with the Burmese isolate. The picture shows 27–34 nm diameter particles aggregated with antibodies present in the serum of a patient infected with HEV.
Figure 3. Genomic organization of HEV. The positions of the genes in the HEV genome are indicated. The genome of HEV, approximately 7.2 kb polyadenylated ribonucleic acid (RNA), contains three open reading frames (ORFs). ORF1 (approximately 5 kb) encodes a putative nonstructural polyprotein, which includes domains found in viral methyltransferases, papain-like cysteine proteases, viral RNA helicases and viral RNA polymerases. ORF2 (approximately 2 kb) encodes the major capsid protein and carries a signal peptide at its N-terminal end and three N-linked glycosylation sites (Asn137, Asn310 and Asn562). ORF3 encodes a small protein with two hydrophobic domains in its N-terminal half, which includes a polycysteine region and a proline-rich transmembrane sequence.
Figure 4. Proposed model of HEV replication and capsid assembly. The virus shown as (¨) enters the cell by an unknown mechanism. After uncoating, the viral genomic RNA is translated into nonstructural (NS) gene products like RNA-dependent RNA polymerase (RdRP), helicase, methyltransferase (methyltr), shown as () and antigenomic RNA shown as (-----). Genomic RNA and sub-genomic mRNAs are produced from the anti-genomic RNA. Viral structural proteins, pORF2 and possibly pORF3 are translated from subgenomic mRNAs. pORF2 is processed in the endoplasmic reticulum and transported to the cis-Golgi complex. Assembly of the virion occurs by the encapsidation of genomic RNA and its association with pORF2 and pORF3. Progeny virions thus formed are ready to exit the cell.
close
 References
    Arankalle VA, Chobe LP and Chadha MS (2006) Type-IV Indian swine HEV infects rhesus monkeys. Journal of Viral Hepatitis 13: 742–745.
    Balayan MS, Andjaparidze AG, Savinskaya SS et al. (1983) Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal–oral route. Intervirology 20: 23–31.
    Emerson SU, Nguyen H, Torian U and Purcell RH (2006) ORF3 protein of hepatitis E virus is not required for replication, virion assembly, or infection of hepatoma cells in vitro. Journal of Virology 80: 10457–10464.
    Jameel S (1999) Molecular biology and pathogenesis of hepatitis E virus. Expert Reviews in Molecular Medicine 1: 1–16.
    Kabrane-Lazizi Y, Meng XJ, Purcell RH et al. (1999) Evidence that the genomic RNA of hepatitis E virus is capped. Journal of Virology 73: 8848–8850.
    Kamili S, Spelbring J, Carson D and Krawczynski K (2004) Protective efficacy of hepatitis E virus DNA vaccine administered by gene gun in the cynomolgus macaque model of infection. The Journal of Infectious Diseases 189: 258–264.
    Khuroo MS (1980) Study of an epidemic of non-A, non-B hepatitis: possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type. American Journal of Medicine 68: 818–823.
    Khuroo MS and Kamili S (2003a) Aetiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy. Journal of Viral Hepatitis 10: 61–69.
    Khuroo MS and Kamili S (2003b) Aetiology and prognostic factors in acute liver failure in India. Journal of Viral Hepatitis 10: 224–314.
    Krawczynski K (2007) Hepatitis E vaccine – ready for prime time? The New England Journal of Medicine 356: 949–951.
    Krawczynski K, Kamili S and Aggarwal R (2001) Global epidemiology and medical aspects of hepatitis E. Forum (Genova) 11: 166–179.
    Li TC, Yamakawa Y, Suzuki K et al. (1997) Expression and self-assembly of empty virus-like particles of hepatitis E virus. Journal of Virology 71: 7207–7213.
    Meng XJ (2003) Swine hepatitis E virus: cross-species infection and risk in xenotransplantation. Current Topics in Microbiology and Immunology 278: 185–216.
    Moin SM, Panteva M and Jameel S (2007) The hepatitis E virus orf3 protein protects cells from mitochondrial depolarization and death. The Journal of Biological Chemistry 282: 21124–21133.
    Okamoto H (2007) Genetic variability and evolution of hepatitis E virus. Virus Research 127: 216–228.
    Panda SK, Thakral D and Rehman S (2007) Hepatitis E virus. Reviews in Medical Virology 17: 151–180.
    Reyes GR, Purdy MA, Kim JP et al. (1990) Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science 247: 1335–1339.
    Shrestha MP, Scott RM, Joshi DM et al. (2007) Safety and efficacy of a recombinant hepatitis E vaccine. The New England Journal of Medicine 356: 895–903.
    Surjit M, Jameel S and Lal SK (2007) Cytoplasmic localization of the ORF2 protein of hepatitis E virus is dependent on its ability to undergo retrotranslocation from the endoplasmic reticulum. Journal of Virology 81: 3339–3345.
    Tam AW, Smith MM, Guerra ME et al. (1991) Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology 185: 120–131.
    Teo CG (2007) The two clinico-epidemiological forms of hepatitis E. Journal of Viral Hepatitis 14: 295–297.
    Tsarev SA, Tsareva TS, Emerson EU et al. (1994) Successful passive and active immunization of cynomolgus monkeys against hepatitis E. Proceedings of the National Academy of Sciences of the USA 91: 10198–10202.
    Tyagi S, Surjit M, Roy AK, Jameel S and Lal SK (2004) The ORF3 protein of hepatitis E virus interacts with liver-specific alpha1-microglobulin and its precursor alpha1-microglobulin/bikunin precursor (AMBP) and expedites their export from the hepatocyte. The Journal of Biological Chemistry 279: 29308–29319.
    Vishwanathan R (1957) Infectious hepatitis in Delhi (1955–56): a critical study: epidemiology. Indian Journal of Medical Research 45(suppl. 1): 1–29.
    Zafrullah M, Ozdener MH, Kumar R et al. (1999) Mutational analysis of glycosylation, membrane translocation and cell surface expression of the hepatitis E virus ORF2 protein. Journal of Virology 73: 4074–4082.
 Further Reading
    book Emerson SU, Anderson D, Arankalle A et al. (2004) "Hepevirus". In: Fauquest CM, Mayo MA, Maniloff J, Desselberger U and Ball LA (eds) Virus Taxonomy: VIIIth Report of the ICTV, pp. 851–855. London: Elsevier.
    book Khuroo MS, Kamili S, Khuroo MS and Ashgar HA (2005) "Hepatitis E". In: Knawy BA, Schiffman ML and Weisner RH (eds) Hepatology: Practical Approach, pp. 111–121. San Diego, CA: Elsevier.
    book Krawczynski K, Aggarwal R and Kamili S (2005) "Epidemiology, clinical and pathologic features, diagnosis, and experimental models". In: Thomas HC, Lemon S and Zuckerman AJ (eds) Viral Hepatitis, pp. 624–634. Malden, MA: Blackwell Publishing.
    book Purcell RH and Emerson SU (2005) "Prevention". In: Thomas HC, Lemon S and Zuckerman AJ (eds) Viral Hepatitis, pp. 635–645. Malden, MA: Blackwell Publishing.
Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

How to Cite close
Kamili, Saleem, and Krawczynski, Krzysztof(Jul 2008) Hepatitis E Virus. In: eLS. John Wiley & Sons Ltd, Chichester. http://www.els.net [doi: 10.1002/9780470015902.a0001030.pub2]